Health systems are facing the biggest challenge in their existence: financial sustainability fuelled by the costs of prescription drugs. Here, Marisa Miraldo, associate professor in health economics at Imperial College Business School, goes into more detail…
New homes
Developing a new drug can cost up to $2.558 billion.1 The rising and unsustainable costs in drug development and the consequent drug cost inflation have been a contentious item in most political agendas and a concern for the industry that claims to have experienced an annual decrease in return on investment in the past six consecutive years.2